Immediate Impact
52 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Maria Reyes being referenced
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
2017
Abstract 3244: Treatment of endometrial cancer cells with a new small tyrosine kinase inhibitor targeting mutated fibroblast growth factor receptor-2
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Maria Reyes | 97 | 62 | 49 | 87 | 77 | 25 | 477 | |
| Kondwani Joseph Banda | 75 | 95 | 120 | 52 | 72 | 46 | 554 | |
| Eric Cheng | 49 | 82 | 15 | 103 | 39 | 24 | 542 | |
| Zeina G. Khodr | 22 | 77 | 51 | 64 | 58 | 22 | 544 | |
| Mini E. Jacob | 26 | 102 | 54 | 73 | 21 | 36 | 471 | |
| M.Z. Mughal | 103 | 21 | 86 | 69 | 47 | 29 | 478 | |
| Sarah Roberts | 86 | 65 | 129 | 140 | 24 | 19 | 456 | |
| Alireza Firouzjahi | 125 | 57 | 49 | 60 | 19 | 27 | 423 | |
| Karen Turpin | 240 | 34 | 43 | 49 | 31 | 13 | 502 | |
| Ellen M. Lavoie Smith | 105 | 66 | 49 | 32 | 84 | 23 | 542 | |
| Peter Malík | 56 | 24 | 48 | 49 | 42 | 26 | 492 |
All Works
Login with ORCID to disown or claim papers
Loading papers...